NIAID CLINICAL PRODUCTS CENTER (CPC)
ID: RFP-NIAID-75N93024R00018Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (AN12)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/c418c9f44b534339939d87e2d6098a32/view
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.

    Point(s) of Contact
    Deborah Blyveis
    (240) 669-5143
    blyveisd@niaid.nih.gov
    Emily Bannister
    emily.bannister@nih.gov
    Files
    Title
    Posted
    RFP-NIAID-75N93024R00018 Final.pdf
    The National Institute of Allergy and Infectious Diseases (NIAID) has issued a Request for Proposal (RFP-NIAID-75N93024R00018) seeking support for pharmacy and pharmaceutical oversight in clinical trials, both national and international. Proposals are due by January 17, 2025, and must be submitted electronically to designated locations. The contract, effective from April 1, 2026, to March 31, 2027, may include options for extending performance through 2033. Offerors must comply with specific reporting requirements, including Technical Progress Reports and adherence to Section 508 of the Rehabilitation Act for accessibility. The contract emphasizes the importance of managing financial conflicts of interest as mandated by federal regulations, ensuring transparency when disclosing potential conflicts. Key personnel in the contract must be specified, with restrictions on diverting their duties without prior approval. Additionally, contractors are obligated to acknowledge federal funding in publicity materials and adhere to various special requirements, including ensuring compliance with NIH’s policies on enhancing reproducibility and public access to research findings. The document outlines comprehensive contractual obligations, emphasizing accountability, transparency, and compliance with federal policies, reinforcing NIAID's commitment to rigorous public health research standards.
    Lifecycle
    Title
    Type
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Currently viewing
    Solicitation
    Similar Opportunities
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the "Preparation and Distribution of Research Drug Products" under solicitation number 75N95024R00003. The primary objective of this procurement is to acquire, analyze, manufacture, and distribute a variety of drug compounds, including controlled substances, to support drug abuse and addiction research. This contract, structured as an indefinite delivery, indefinite quantity (IDIQ) agreement, is expected to span five years and will allow for both cost reimbursement and fixed-price task orders based on NIDA's needs. Interested offerors must submit their proposals electronically by November 15, 2024, and ensure compliance with federal acquisition regulations, including maintaining active registration in the System for Award Management (SAM). For further inquiries, potential bidders can contact Scott Duernberger at scott.duernberger@nih.gov or Josh Lazarus at josh.lazarus@nih.gov.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Controls (CMC) services related to the development of drug substances, as outlined in RFP Number 75N95024R00094. The primary objective is to ensure the provision of high-quality drug substances to support preclinical and Investigational New Drug (IND)-enabling studies, which are critical for advancing therapeutic innovations. This opportunity emphasizes compliance with current Good Manufacturing Practices (cGMP) and requires detailed reporting and documentation throughout the contract period. Interested contractors should note that the proposal submission deadline is December 3, 2024, with a maximum funding amount of $49.7 million anticipated for the contract period from September 1, 2025, to May 14, 2031. For further inquiries, potential bidders can contact Samson Shifaraw at samson.shifaraw@nih.gov or Valerie Whipple at valerie.whipple@nih.gov.
    A--BPCA Pediatric Trials Network
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for an Indefinite Quantity Contract to establish and maintain an infrastructure for conducting pediatric clinical trials under the Best Pharmaceuticals for Children Act (BPCA). The primary objective is to create a Pediatric Trials Network (PTN) that will facilitate the development of safe and effective medications for children, ensuring compliance with federal regulations regarding human subjects and quality control in clinical trials. This initiative is crucial for advancing pediatric drug development and promoting ethical research practices, with a contract performance period from May 19, 2025, to May 18, 2033, and a funding range between $2,500 and $149 million based on performance. Interested contractors must submit their proposals by November 4, 2024, at 4:30 PM EST, and can direct inquiries to Elizabeth J. Osinski at eo43m@nih.gov or call 240-550-5028.
    Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for the establishment of a Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB). This initiative aims to coordinate and conduct the design, synthesis, and testing of chemical libraries of novel small molecules and natural products targeting Gram-negative bacterial pathogens, addressing the critical issue of multidrug-resistant bacteria. The contract will encompass four key areas: Library Design, Compound Synthesis, Compound Testing, and Compound Management, with an estimated 28,000 direct labor hours required for the base year and each option period. Proposals must be submitted electronically via the NIAID electronic Contract Proposal Submission (eCPS) website, with the RFP expected to be available on or about November 30, 2024. Interested parties can contact Aytaj Vily at aytaj.vily@nih.gov or 301-761-5131 for further information.
    A--NIH NeuroBioBank Brain and Tissue Repository
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is soliciting proposals for the establishment of the NIH NeuroBioBank Brain and Tissue Repository under Request for Proposal (RFP) No. 75N95024R00124. The objective of this procurement is to create and manage contract collection sites for acquiring, storing, and distributing human brain and central nervous system tissues for research, aimed at advancing the understanding and treatment of nervous system disorders. This initiative is critical for enhancing biomedical research by improving access to well-characterized specimens, thereby supporting scientific investigations into neurological conditions. Proposals are due by November 14, 2024, with the anticipated contract performance period starting on May 1, 2025, and extending through optional years. Interested parties can direct inquiries to Robin D. Knightly at robin.knightly@nih.gov or call +1 301 827 5302 for further information.
    Scientific Management and Support to the National Institute of Mental Health (NIMH) Repository and Genomics Resource (NRGR)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for scientific management and support services for the National Institute of Mental Health Repository and Genomics Resource (NRGR). The objective of this procurement is to sustain, enhance, and enrich the NRGR, which provides critical biospecimens and genomic data for research on psychiatric disorders, thereby facilitating a deeper understanding of the genetic factors associated with mental health. This initiative is vital for advancing research in the genetics of mental disorders and ensuring broad access to valuable biospecimens and data resources for the scientific community. Proposals are due by November 8, 2024, and must be submitted electronically via the NIH's eCPS system; interested parties should contact Sarah Adan at sarah.adan@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    A--Clinical Research Operations and Management (CROMS)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for Clinical Research Operations and Management Services (CROMS). The objective of this procurement is to enhance the management and operational support for clinical research initiatives, which are critical for advancing health-related research and development. This opportunity is particularly significant as it aligns with the NIH's mission to improve public health through innovative research solutions. Interested parties should note that the question deadline has been amended to October 28, 2024, and the previously scheduled webinar on October 25, 2024, has been canceled. For further inquiries, potential bidders can contact Natalie Bruning at natalie.bruning@nih.gov or by phone at 301-827-7528.
    Reagent Generation for Bioanalytical Method Development on Biologics
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified sources for a potential contract focused on reagent generation for bioanalytical method development related to biologics. The primary objective is to obtain information on the availability and capability of companies to generate and deliver reagents, including anti-drug antibodies, that support the quantification of novel biologic drugs in various biological matrices. This initiative is crucial for advancing drug development processes and improving success rates in preclinical stages, with the Therapeutic Development Branch (TDB) at NIH playing a pivotal role in moving therapeutic candidates through the drug development pipeline. Interested parties must submit their capability statements by November 8, 2024, to Nick Niefeld at nick.niefeld@nih.gov, referencing sources sought notice number 75N95025R00007.
    CRO Support for NCATS Bioanalytical Method Development for Biologics
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified contractors to provide support for bioanalytical method development for biologics under a Sources Sought notice. The primary objective is to identify capable organizations that can develop and validate bioanalytical methods for quantitative analyses of novel therapeutic biologics and anti-drug antibodies in various biological matrices, as well as manage project administration and quality assurance. This initiative is crucial for advancing drug development processes and ensuring compliance with regulatory standards, ultimately facilitating the transition of therapeutic candidates to clinical trials. Interested parties must submit their capability statements and relevant information by November 8, 2024, to Nick Niefeld at nick.niefeld@nih.gov.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Center for Advancing Translational Sciences (NCATS), is seeking qualified small businesses to provide Chemistry, Manufacturing, and Controls (CMC) and related services for the development of drug products. The objective of this procurement is to support the Therapeutic Development Branch in ensuring the delivery of drug products of sufficient quality and quantity for preclinical, IND-enabling, and clinical studies, which are critical for advancing therapeutic candidates through the drug development pipeline. This opportunity is part of a Small Business Sources Sought notice, aimed at gathering information on the capabilities of small businesses to fulfill these requirements, with a focus on compliance with applicable regulations and the potential for a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract. Interested vendors must submit their capability statements by 10:00 AM Eastern Time on July 21, 2024, to Michelle Cecilia at michelle.cecilia@nih.gov.